
A safety warning has been issued by the national medicines regulator over a so-called "Hollywood drug" used to treat type 2 diabetes and obesity.
The Therapeutic Goods Association has updated its product information for the relatively new class of medicines known as GLP-1 receptor agonists, warning of an increased risk of potential suicidal ideation.